363 related articles for article (PubMed ID: 34777359)
1. Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.
Liu J; Chen C; Wang Y; Qian C; Wei J; Xing Y; Bai J
Front Immunol; 2021; 12():746647. PubMed ID: 34777359
[TBL] [Abstract][Full Text] [Related]
2. m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma.
Tong C; Wang W; He C
BMC Gastroenterol; 2022 Mar; 22(1):93. PubMed ID: 35240991
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
4. Landscape of N1-methyladenosin (m1A) modification pattern in colorectal cancer.
Jiang C; Tian Y; Xu C; Zhang H; Gu L
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1965. PubMed ID: 38115786
[TBL] [Abstract][Full Text] [Related]
5. The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma.
Gao L; Chen R; Sugimoto M; Mizuta M; Kishimoto Y; Omori K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638642
[TBL] [Abstract][Full Text] [Related]
6. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
7. m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma.
Zhou L; Zhou W; Li Y; Hua R
Eur J Med Res; 2023 Sep; 28(1):321. PubMed ID: 37679761
[TBL] [Abstract][Full Text] [Related]
8. Integrated analyses of m
Gao Y; Wang H; Li H; Ye X; Xia Y; Yuan S; Lu J; Xie X; Wang L; Zhang J
Oncoimmunology; 2021 Jun; 10(1):1936758. PubMed ID: 34221700
[TBL] [Abstract][Full Text] [Related]
9. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Ye W; Huang T
PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
[TBL] [Abstract][Full Text] [Related]
10. The joint role of methylation and immune-related lncRNAs in ovarian cancer: Defining molecular subtypes and developing prognostic signature.
Gao K; Lian W; Zhao R; Huang W; Xiong J
Transl Oncol; 2023 Aug; 34():101704. PubMed ID: 37257331
[TBL] [Abstract][Full Text] [Related]
11. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
Zhao M; Shen S; Xue C
Front Immunol; 2022; 13():805967. PubMed ID: 35401564
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma.
Bao G; Li T; Guan X; Yao Y; Liang J; Xiang Y; Zhong X
Front Oncol; 2022; 12():882292. PubMed ID: 35712502
[TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
14. Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer.
Liu J; Chen C; Geng R; Shao F; Yang S; Zhong Z; Ni S; Bai J
Comput Struct Biotechnol J; 2022; 20():5440-5452. PubMed ID: 36249562
[TBL] [Abstract][Full Text] [Related]
15. m
Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.
Gao Y; Chen L; Cai G; Xiong X; Wu Y; Ma D; Li SC; Gao Q
Oncoimmunology; 2020; 9(1):1760067. PubMed ID: 32391193
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
19. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
Luo Y; Sun X; Xiong J
Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
[No Abstract] [Full Text] [Related]
20. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
